📣 VC round data is live. Check it out!
- Public Comps
- Crescent Capital BDC
Crescent Capital BDC Valuation Multiples
Discover revenue and EBITDA valuation multiples for Crescent Capital BDC and similar public comparables like Ophir High Conviction, Idun Industrier, International Biotechnology Trust, Bosqar and more.
Crescent Capital BDC Overview
About Crescent Capital BDC
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
Founded
2015
HQ

Employees
230
Website
Sectors
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialCrescent Capital BDC Financials
Crescent Capital BDC reported last 12-month revenue of $161M.
In the same LTM period, Crescent Capital BDC generated $35M in net income.
Revenue (LTM)
Crescent Capital BDC P&L
In the most recent fiscal year, Crescent Capital BDC reported revenue of $167M and net income of $35M.
Crescent Capital BDC is profitable as of last fiscal year, with net margin of 21%.
Financial data powered by Morningstar, Inc.
Crescent Capital BDC Stock Performance
Crescent Capital BDC has current market cap of $419M, and enterprise value of $1B.
Market Cap Evolution
Crescent Capital BDC's stock price is $11.38.
Crescent Capital BDC share price decreased by 16.4% in the last 30 days, and by 26.7% in the last year.
Crescent Capital BDC has an EPS (earnings per share) of $0.94.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $419M | 0.0% | -16.4% | -10.1% | -26.7% | $0.94 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCrescent Capital BDC Valuation Multiples
Crescent Capital BDC trades at 8.2x EV/Revenue multiple.
EV / Revenue (LTM)
Crescent Capital BDC Financial Valuation Multiples
As of May 25, 2026, Crescent Capital BDC has market cap of $419M and EV of $1B.
Crescent Capital BDC has a P/E ratio of 12.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Crescent Capital BDC Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Crescent Capital BDC Margins & Growth Rates
Crescent Capital BDC decreased revenue by 10% but net profit grew by 4% in the last fiscal year.
In the most recent fiscal year, Crescent Capital BDC reported net margin of 21%.
Crescent Capital BDC Margins
Crescent Capital BDC Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Crescent Capital BDC Operational KPIs
Crescent Capital BDC's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.4M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Crescent Capital BDC Competitors
Crescent Capital BDC competitors include Ophir High Conviction, Idun Industrier, International Biotechnology Trust, Bosqar, Metrics Income Opportunities Trust, Whitefield Industrials, Fiera Capital, Gladstone Cap, MCI Capital and Fundo DE Investimento.
Most Crescent Capital BDC public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.5x | — | — | — | |||
| 2.1x | 2.0x | 13.0x | 12.1x | |||
| (1975.9x) | — | — | — | |||
| 1.7x | — | 14.4x | — | |||
| 8.9x | — | — | — | |||
| 21.9x | — | — | — | |||
| 2.0x | 2.0x | 6.8x | 6.7x | |||
| 9.2x | 8.5x | — | — | |||
This data is available for Pro users. Sign up to see all Crescent Capital BDC competitors and their valuation data. Start Free Trial | ||||||
Crescent Capital BDC M&A Activity
Crescent Capital BDC has acquired 1 company to date.
Last acquisition by Crescent Capital BDC was on August 13th 2019. Crescent Capital BDC acquired Alcentra Capital Corporation for $142M (EV/Revenue multiple of ).
Latest Acquisitions by Crescent Capital BDC
| Description | Alcentra Capital Corporation is a New York-headquartered business development company founded in 2007 that provides subordinated debt, senior loans, and equity to lower middle-market companies in the United States. Regulated under the Investment Company Act, it targets firms with EBITDA of $10-50 million, generating income through a diversified portfolio of over 20 investments. |
| HQ Country | |
| HQ City | New York City, NY |
| Deal Date | 13 Aug 2019 |
| Valuation | $142M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Crescent Capital BDC acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Crescent Capital BDC
| When was Crescent Capital BDC founded? | Crescent Capital BDC was founded in 2015. |
| Where is Crescent Capital BDC headquartered? | Crescent Capital BDC is headquartered in United States. |
| How many employees does Crescent Capital BDC have? | As of today, Crescent Capital BDC has over 230 employees. |
| Who is the CEO of Crescent Capital BDC? | Crescent Capital BDC's CEO is Jason Breaux. |
| Is Crescent Capital BDC publicly listed? | Yes, Crescent Capital BDC is a public company listed on Nasdaq. |
| What is the stock symbol of Crescent Capital BDC? | Crescent Capital BDC trades under CCAP ticker. |
| When did Crescent Capital BDC go public? | Crescent Capital BDC went public in 2020. |
| Who are competitors of Crescent Capital BDC? | Crescent Capital BDC main competitors include Ophir High Conviction, Idun Industrier, International Biotechnology Trust, Bosqar, Metrics Income Opportunities Trust, Whitefield Industrials, Fiera Capital, Gladstone Cap, MCI Capital, Fundo DE Investimento. |
| What is the current market cap of Crescent Capital BDC? | Crescent Capital BDC's current market cap is $419M. |
| What is the current revenue of Crescent Capital BDC? | Crescent Capital BDC's last 12 months revenue is $161M. |
| What is the current revenue growth of Crescent Capital BDC? | Crescent Capital BDC revenue growth (NTM/LTM) is (7%). |
| What is the current EV/Revenue multiple of Crescent Capital BDC? | Current revenue multiple of Crescent Capital BDC is 8.2x. |
| Is Crescent Capital BDC profitable? | Yes, Crescent Capital BDC is net-income-positive (as of the last 12 months). |
| What is the current net income of Crescent Capital BDC? | Crescent Capital BDC's last 12 months net income is $35M. |
| How many companies Crescent Capital BDC has acquired to date? | As of May 2026, Crescent Capital BDC has acquired 1 company. |
| What was the largest acquisition by Crescent Capital BDC? | $142M acquisition of Alcentra Capital Corporation on 13th August 2019 was the largest M&A Crescent Capital BDC has done to date. |
| What companies Crescent Capital BDC acquired? | Crescent Capital BDC acquired Alcentra Capital Corporation. |
| In how many companies Crescent Capital BDC has invested to date? | Crescent Capital BDC hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Crescent Capital BDC
Lists including Crescent Capital BDC
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
